Event co-organizer the Taiwan Bio Industry Organization (Taiwan BIO), stated that international participation was notably higher this year due to the lifti...
The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Eve...
Calder Biosciences Inc., a molecular engineering and clinical manufacturing-stage biotechnology company pioneering its 3D-Vaxlockä platform techn...
SCIEX, a global leader in life science analytical technologies, launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform...
Agilent Technologies Inc. (NYSE: A) announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, b...
Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023...
Veeva Systems (NYSE: VEEV) announced that leaders from Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, and Syneos Health are among the speak...
With around 5,000 global manufacturers spanning the healthcare supply chain, the CMEF organized by Reed Sinopharm Exhibitions is unparalleled in its scale,...
GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magn...
As a Siemens Healthineers company, Varian is working to connect the cancer care continuum to empower clinicians to deliver more efficient, more personalize...
Details of the events are as follows: Event: Event: BIO International ConventionDate: June 5-8, 2023Registration: https://www.bio.org/events/bio-internati...
"We are proud to recognize Pfizer Oncology as the recipient of the 2023 Health Science Award," said Edward M. Messing, MD, FACS, president of the AUA. "Pfi...
As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...
The Phase 3 ELEVATE study demonstrated atogepant is effective and well-tolerated for the preventive treatment of episodic migraine in people who previous...
© 2025 Biopharma Boardroom. All Rights Reserved.
